Stock Events

Stock Events

Hisamitsu Pharmaceutical 

$2.94
6
-$0.00-0% Monday 20:00

Statistics

Day High
-
Day Low
-
52W High
6.8
52W Low
2.94
Volume
-
Avg. Volume
8
Mkt Cap
0
P/E Ratio
7
Dividend Yield
6.01%
Dividend
0.18

Upcoming

28
AUG
Dividend Ex
Estimated
 
20
NOV
Dividend Payment
Estimated
 
1
MAR 27
Dividend Ex
Estimated
 
9
JUN 27
Dividend Payment
Estimated
 
30
AUG 27
Dividend Ex
Estimated
 
19
NOV 27
Dividend Payment
Estimated
 

Dividends

6.01%Dividend Yield
Nov 25
$0.10
Jun 25
$0.08
Nov 24
$0.07
Jun 24
$0.07
Nov 23
$0.07
10Y Growth
N/A
5Y Growth
-12.13%
3Y Growth
-12.42%
1Y Growth
-44.6%

Earnings

9JulExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Next
0.24
0.41
0.57
0.73
Expected EPS
0.3223726
Actual EPS
N/A

Financials

13.94%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
2.07BRevenue
288.44MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Novartis
NVS
Mkt Cap293.94B
Novartis is a global healthcare company that manufactures drugs across various therapeutic areas, including pain management, directly competing with Hisamitsu's products.
Johnson & Johnson
JNJ
Mkt Cap618.61B
Johnson & Johnson offers a broad range of health products, including pharmaceuticals that compete in the pain relief and dermatology sectors, similar to Hisamitsu.
GSK
GSK
Mkt Cap105.71B
GlaxoSmithKline focuses on pharmaceuticals and healthcare products, including skin health solutions and pain relief medications, competing with Hisamitsu.
Pfizer
PFE
Mkt Cap137.76B
Pfizer operates globally in various therapeutic areas, including pain management, which overlaps with Hisamitsu's product offerings.
Sanofi
SNY
Mkt Cap104.13B
Sanofi produces a wide range of pharmaceutical products, including those for pain relief, directly competing with Hisamitsu's core areas.
Merck
MRK
Mkt Cap305.12B
Merck produces pharmaceuticals that address various health conditions, including pain and skin health, competing with Hisamitsu.
Abbvie
ABBV
Mkt Cap438.31B
AbbVie, a research-based biopharmaceutical company, has products in dermatology and pain management, directly competing with Hisamitsu.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap38.37B
Teva Pharmaceutical Industries specializes in generic and specialty medicines, including pain management therapies, competing in Hisamitsu's market.

About

Hisamitsu Pharmaceutical Co., Inc. is a company dedicated to the entire lifecycle of healthcare products, from initial research and development to manufacturing and global distribution of pharmaceuticals and related health solutions. It is particularly recognized for its well-known brands such as Salonpas, Salonsip, Mohrus, ByeBye-Fever, and Keplat. Beyond these, Hisamitsu's diverse portfolio encompasses prescription-only medicines, over-the-counter remedies, medical devices, nutritional supplements, and a range of topical products designed for pain relief. Established by Nihei Hisamitsu in 1847, the company maintains its corporate headquarters in Tosu, Japan.
Show more...
CEO
Mr. Kazuhide Nakatomi
Employees
2769
Country
United States
ISIN
US43358N1072

Listings

OTC Link
US
HTSUY
STU
DE
HPX.STU

0 Comments

Share your thoughts

FAQ

What is Hisamitsu Pharmaceutical stock price today?▼
The current price of HTSUY is $2.94 USD — it has decreased by -0% in the past 24 hours. Watch Hisamitsu Pharmaceutical stock price performance more closely on the chart.
What is Hisamitsu Pharmaceutical stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Hisamitsu Pharmaceutical stocks are traded under the ticker HTSUY.
Is Hisamitsu Pharmaceutical stock price growing?▼
HTSUY stock has risen by +0% compared to the previous week, the month change is a -0% fall, over the last year Hisamitsu Pharmaceutical has showed a -56.73% decrease.
What is Hisamitsu Pharmaceutical revenue for the last year?▼
Hisamitsu Pharmaceutical revenue for the last year amounts to 2.07B USD.
What is Hisamitsu Pharmaceutical net income for the last year?▼
HTSUY net income for the last year is 288.44M USD.
Does Hisamitsu Pharmaceutical pay dividends?▼
Yes, HTSUY dividends are paid semi-annual. The last dividend per share was 0.1 USD. As of today, Dividend Yield (FWD)% is 6.01%.
How many employees does Hisamitsu Pharmaceutical have?▼
As of July 13, 2026, the company has 2,769 employees.
In which sector is Hisamitsu Pharmaceutical located?▼
Hisamitsu Pharmaceutical operates in the Other sector.
When did Hisamitsu Pharmaceutical complete a stock split?▼
Hisamitsu Pharmaceutical has not had any recent stock splits.
Where is Hisamitsu Pharmaceutical headquartered?▼
Hisamitsu Pharmaceutical is headquartered in Tosu, United States.